Mastitis (various pathogens)

Mastitis represents the most economically significant disease affecting dairy cattle worldwide, characterized by inflammation of the mammary gland typically resulting from bacterial infection. The condition encompasses a wide spectrum of clinical presentations ranging from mild subclinical infections detectable only through milk testing to severe systemic disease threatening animal survival. Understanding mastitis requires recognition of its complex etiology involving multiple pathogen types, host factors, environmental influences, and management practices. The persistent challenge of mastitis control reflects the ongoing interaction between infectious agents seeking to colonize a nutrient-rich environment and the animal's defense mechanisms working to maintain udder health.

Mastitis affects dairy operations across all geographic regions, production systems, and management intensities. Clinical mastitis incidence rates typically range from 20 to 40 cases per 100 cows annually in well-managed herds, though rates exceeding 60 cases per 100 cows occur in herds with significant control problems. Subclinical mastitis prevalence, measured through somatic cell count elevation, affects 25 to 50 percent of quarters in many herds. The condition impacts all dairy species including cattle, goats, sheep, and buffalo, with cattle representing the primary economic concern due to industry scale. Both organic and conventional production systems face mastitis challenges requiring adapted management strategies.

The economic impact of mastitis on dairy operations encompasses multiple cost categories that collectively represent the largest disease-related expense in dairy production. Direct losses include discarded milk during treatment and withdrawal periods, reduced milk production from affected quarters, veterinary and treatment costs, and increased labor for detection and care. Indirect losses include premature culling of chronically infected animals, reduced milk quality premiums, impaired reproductive performance, and replacement costs. Total mastitis costs are estimated at 100 to 300 dollars per cow annually, representing billions of dollars in losses across the global dairy industry. Beyond economics, animal welfare concerns including pain, discomfort, and illness severity drive ethical considerations for mastitis prevention and treatment.

The treatability of mastitis varies considerably based on causative pathogen, infection duration, and host factors. Many acute clinical cases respond favorably to appropriate antimicrobial therapy combined with supportive care. Subclinical infections with certain pathogens achieve high bacteriological cure rates when treated during the dry period. However, some organisms, particularly Staphylococcus aureus and Mycoplasma species, resist conventional treatment and establish chronic infections persisting throughout the cow's productive life. Early detection through regular monitoring, prompt appropriate treatment, and comprehensive prevention programs remain fundamental to successful mastitis management.

The primary causes of mastitis involve bacterial invasion of the mammary gland through the teat canal, with pathogens traditionally classified as either contagious or environmental based on their primary reservoir and transmission patterns. Contagious mastitis pathogens including Staphylococcus aureus, Streptococcus agalactiae, Mycoplasma species, and Corynebacterium bovis spread primarily from infected udders to uninfected cows during the milking process. Environmental mastitis pathogens including Escherichia coli, Klebsiella species, Streptococcus uberis, Streptococcus dysgalactiae, and various other organisms reside in the cow's surroundings and cause opportunistic infections when teat exposure occurs. Coagulase-negative staphylococci represent an intermediate group causing infections of varying clinical significance.

Genetic and breed predispositions influence mastitis susceptibility through multiple mechanisms including udder conformation, teat characteristics, and immune function traits. Cows with pendulous udders, large teat orifices, or weak teat sphincters face increased pathogen entry risk. Genetic variation exists in neutrophil function, immunoglobulin production, and inflammatory response patterns affecting infection resistance and resolution. Holstein cattle, while predominating in commercial dairy operations, demonstrate variable mastitis resistance across genetic lines. Jersey, Guernsey, and Brown Swiss breeds show generally favorable udder health characteristics. Selection indices incorporating somatic cell score and clinical mastitis incidence allow genetic improvement of mastitis resistance.

Environmental and management factors profoundly influence mastitis incidence through pathogen exposure levels, cow comfort, and teat condition effects. Housing systems, bedding materials, stocking density, and manure management determine environmental bacterial loads. Milking equipment maintenance, proper function, and appropriate settings affect teat tissue integrity and pathogen transmission risk. Parlor hygiene practices including teat preparation, glove use, and post-milking teat disinfection directly influence infection dynamics. Dry cow management, transition period care, and nutrition impact immune function and mastitis susceptibility during high-risk periods.

Risk factors for mastitis vary somewhat based on pathogen type but share common themes. Lactation stage influences susceptibility, with early lactation cows facing elevated risk due to metabolic stress and immune suppression. Older cows with more lactations demonstrate increased mastitis incidence due to cumulative teat damage and prior infections. Teat lesions, chapping, or injuries provide pathogen entry opportunities. Concurrent diseases including ketosis, hypocalcemia, and retained placenta impair immune function. High milk production, while economically desirable, correlates with increased mastitis risk through physiological stress and environmental exposure.

The pathophysiology of mastitis begins when bacteria overcome teat canal defenses and establish growth within the mammary cistern and glandular tissue. Initial bacterial multiplication triggers recognition by tissue-resident immune cells, initiating inflammatory cascades that recruit neutrophils and other leukocytes from the bloodstream. Inflammatory mediators cause tissue damage, altered vascular permeability, and changes in milk composition characteristic of elevated somatic cell counts. Severe infections may progress to systemic involvement with toxemia, bacteremia, and multi-organ effects. Chronic infections can result in permanent tissue damage through fibrosis, abscessation, or granuloma formation that reduces productive capacity.

Early warning signs of developing mastitis may be subtle and require attentive observation during milking for reliable detection. Changes in milk appearance including wateriness, flakes, clots, or discoloration indicate inflammatory processes within the gland. Reduced milk flow from individual quarters during milking may precede obvious clinical signs. Mild swelling or firmness detectable during pre-milking udder evaluation suggests early inflammation. California Mastitis Test reactions transitioning from negative to trace or weak positive identify developing subclinical infections. Slight asymmetry between quarters during letdown or persistent residual milk in affected quarters warrant investigation.

Common symptoms differ somewhat between dairy cattle, goats, and sheep due to species-specific characteristics. In dairy cattle, clinical mastitis typically presents with visible milk abnormalities, udder swelling, and variable systemic signs depending on severity. Dairy goats may show similar local signs but often develop more rapid systemic illness with certain pathogens. Dairy ewes nursing lambs may first be detected when lambs become unthrifty due to reduced milk availability or quality. Half-udder involvement in sheep reflects their bilobed mammary anatomy. All species may demonstrate reduced appetite, fever, and decreased activity when systemic involvement occurs.

Behavioral changes associated with mastitis reflect pain, systemic illness, and reduced wellbeing. Affected animals may separate from the herd, seeking isolated areas for rest. Reluctance to walk or abnormal gait may indicate udder discomfort, particularly with severe swelling. Reduced feed intake often precedes obvious clinical signs and persists during active infection. Changes in lying behavior, including reluctance to lie on affected sides or difficulty rising, suggest discomfort. Decreased rumination activity indicates systemic illness impacting normal digestive function. Agitation during milking, kicking at the udder, or resistance to udder touching reflects local pain.

Physical signs of clinical mastitis include visible changes in the udder and systemic manifestations. Quarter swelling ranges from subtle firmness to dramatic enlargement with skin tension and edema. Affected quarters feel hot on palpation and demonstrate increased sensitivity to touch. Skin over inflamed quarters may appear reddened, develop a waxy texture, or show bluish discoloration in gangrenous cases. Teat swelling and changes in teat color may occur. Fever accompanies many clinical cases, though temperatures may decrease below normal in severe toxic mastitis. Dehydration, sunken eyes, and tucked abdomen indicate systemic illness severity.

Symptom progression follows predictable patterns based on causative organism and treatment adequacy. Environmental coliform mastitis typically progresses rapidly, with mild initial signs escalating to severe systemic illness within hours. Staphylococcus aureus often causes recurring clinical flares interspersed with subclinical periods. Streptococcal mastitis generally produces consistent clinical signs that respond predictably to appropriate therapy. Mycoplasma mastitis may spread sequentially through quarters with persistent shedding despite treatment. Untreated or inadequately treated infections may become chronic with episodes of clinical disease alternating with subclinical persistence.

Emergency symptoms requiring immediate veterinary intervention include rapid onset of severe systemic illness with high fever, profound depression, and complete anorexia. Toxic mastitis presents with cold, discolored quarters producing watery, serum-like secretions often tinged with blood. Affected cows may become recumbent and unable to rise. Signs of shock including rapid heart rate, pale mucous membranes, and cold extremities indicate critical illness. Gangrenous mastitis with black or sloughing udder tissue represents a life-threatening emergency. Any cow showing rapid deterioration despite initial treatment requires immediate veterinary reassessment.

Clinical examination for mastitis diagnosis begins with systematic evaluation of each quarter before milking. Visual inspection identifies gross swelling, asymmetry, or skin changes. Palpation assesses tissue consistency, warmth, and pain response compared between quarters and to expected normal findings. Stripping milk into a strip cup or dark surface reveals visual abnormalities including clots, flakes, color changes, or watery consistency. Systematic examination ensures mild cases in less obvious quarters are not overlooked. Physical examination including temperature measurement, heart rate, and assessment of appetite and attitude evaluates systemic involvement.

Diagnostic testing for mastitis employs multiple methodologies for different purposes. California Mastitis Test provides rapid, cow-side assessment of inflammatory cell content in milk, useful for subclinical mastitis detection and quarter identification. Somatic cell count quantifies inflammatory cells precisely, with counts above 200,000 cells per milliliter indicating probable infection. Bacteriological culture of aseptically collected milk samples remains the gold standard for pathogen identification and antimicrobial susceptibility determination. Polymerase chain reaction testing enables rapid identification of specific pathogens including those difficult to culture. On-farm culture systems allow pathogen identification within 24 hours to guide treatment decisions.

Differential diagnosis for clinical mastitis requires consideration of other conditions causing udder abnormalities or systemic illness. Udder edema, particularly common in fresh cows, causes swelling without infection and resolves with time and management. Udder hematoma from trauma produces painful swelling that may be confused with mastitis. Teat injuries can cause secondary mastitis but may initially present without intramammary infection. Systemic diseases including toxic metritis, pneumonia, or digestive disorders may cause fever and depression without udder involvement. Milk contamination during sample collection can yield misleading culture results.

Herd-level diagnostics provide population-based insights essential for strategic mastitis control. Bulk tank somatic cell count reflects overall herd udder health status and affects milk quality premiums. Bulk tank culture identifies pathogens present in the milking herd, with Staphylococcus aureus and Streptococcus agalactiae warranting particular concern. Individual cow somatic cell count records analyzed over time reveal chronic infections, new infection patterns, and cure rates. Clinical mastitis incidence tracking by stage of lactation, parity, and season identifies risk factors and monitors control program effectiveness. Regular culture programs with representative sampling guide treatment protocols and prevention priorities.

Emergency treatment for severe clinical mastitis prioritizes life-saving supportive care alongside antimicrobial therapy. Intravenous fluid administration combats dehydration and shock, restoring circulating volume and supporting cardiovascular function. Anti-inflammatory medications reduce fever, pain, and systemic inflammatory response. Non-steroidal anti-inflammatory drugs approved for dairy cattle provide effective symptomatic relief. Frequent complete milking of affected quarters removes bacteria, toxins, and inflammatory products from the udder. Oxytocin administration facilitates milk letdown and complete emptying. Calcium supplementation addresses hypocalcemia that frequently complicates severe periparturient mastitis.

Medical management of clinical mastitis centers on antimicrobial therapy selected based on known or suspected pathogen characteristics. Intramammary infusion products deliver high local drug concentrations directly to the infection site. Systemic antibiotics reach infected tissues through blood supply and may be necessary for severe or deep-seated infections. Treatment duration varies by product, pathogen, and clinical response, with most protocols recommending three to five days of intramammary therapy. Milk and meat withdrawal times must be observed strictly, with all treated animals clearly identified. Culture-guided therapy using on-farm or laboratory results optimizes antimicrobial selection and reduces unnecessary drug use.

Surgical intervention for mastitis complications addresses specific anatomical problems. Teat obstructions from infection-related scarring or fibrin deposits may require careful cannulation or thelotomy. Milk fistulas occasionally develop following severe teat injuries with secondary mastitis. Abscess drainage may be necessary for localized purulent collections unresponsive to medical therapy. Quarter amputation represents a salvage procedure for gangrenous quarters threatening systemic health. All surgical procedures require appropriate anesthesia, sterile technique, and antimicrobial coverage.

Supportive care enhances recovery and cow comfort during mastitis treatment. Clean, dry, well-bedded housing provides optimal conditions for healing. Separation from the main herd reduces stress and allows closer monitoring. Frequent milking, often four times daily for severe cases, promotes drainage and resolution. Fresh water and palatable feeds maintain intake despite reduced appetite. Protection from heat stress supports immune function. Gentle handling during treatment maintains cow cooperation and reduces stress responses.

Herd treatment protocols establish standardized approaches based on local pathogen patterns and treatment outcomes. Treatment trees guide therapy decisions based on clinical severity, lactation stage, and prior treatment history. Dry cow therapy protocols address subclinical infections and prevent new infections during the non-lactating period. Selective dry cow therapy targets antimicrobial use to infected quarters while using teat sealants alone for uninfected quarters. Extended lactation therapy for chronic Staphylococcus aureus infections uses prolonged intramammary treatment to improve cure rates. Protocols should be developed with veterinary input and regularly evaluated for effectiveness.

Treatment decisions must balance individual cow welfare, economics, and food safety considerations. Spontaneous cure without treatment occurs for some mild clinical cases, particularly those caused by environmental pathogens. Economic analysis comparing treatment costs to expected returns guides decisions for cows with guarded prognosis. Chronic infections with Staphylococcus aureus or Mycoplasma often justify culling rather than repeated failed treatments. All treatments must be recorded with drug identity, dose, route, and withdrawal dates. Residue avoidance programs protect milk supply integrity and public health.

Recovery timeline for mastitis varies considerably based on causative pathogen, infection severity, treatment adequacy, and individual cow factors. Mild clinical cases caused by environmental streptococci typically show clinical improvement within 24 to 48 hours of treatment initiation, with return to normal milk within 3 to 5 days. Coliform mastitis survivors often require a week or more to recover completely following severe systemic illness. Staphylococcal infections may show clinical cure while remaining bacteriologically positive, persisting as subclinical infections. Quarter function may be permanently impaired following severe infections regardless of pathogen.

Post-treatment care and monitoring ensures complete recovery and identifies treatment failures requiring additional intervention. Daily visual and physical assessment of treated quarters monitors resolution of inflammation and milk abnormalities. Milk cultures collected 2 to 3 weeks after treatment completion confirm bacteriological cure. Somatic cell count monitoring identifies persistent subclinical infection in clinically recovered quarters. Cows failing to respond to initial therapy may require extended treatment, alternative antimicrobials, or reassessment of diagnosis. Return to the main milking herd should occur only after clinical recovery and withdrawal period completion.

Prognosis factors influencing mastitis outcomes include pathogen identity, chronicity of infection, and degree of tissue damage. Infections detected and treated early generally carry favorable prognosis for complete recovery. Staphylococcus aureus infections have lower cure rates than streptococcal infections, particularly when chronic. First-lactation cows typically achieve better cure rates than older animals with more extensive udder damage. Quarter location affects prognosis, with rear quarters sometimes responding differently than front quarters. Concurrent diseases and metabolic stress reduce immune function and recovery capacity.

Return to production considerations following mastitis recovery include verification of normal milk quality and withdrawal period completion. Bulk tank eligibility requires negative antibiotic screening tests and return of individual cow somatic cell counts to acceptable levels. Production from recovered quarters may remain below pre-infection levels permanently following severe cases. Reproductive performance monitoring ensures mastitis-associated reproductive suppression resolves with recovery. Long-term somatic cell count tracking identifies cows with chronic subclinical infection warranting dry cow therapy or culling decisions.

Vaccination protocols for mastitis prevention target specific pathogen groups with variable efficacy. Core gram-negative vaccines using Escherichia coli J5 bacterin stimulate antibodies reducing severity of coliform mastitis. Administration during the dry period and near calving maximizes protective antibody levels in colostrum and early lactation milk. Staphylococcus aureus vaccines have shown inconsistent field efficacy despite laboratory evidence of immune response generation. Novel vaccines targeting specific virulence factors continue development. Vaccination programs should be designed with veterinary consultation based on herd pathogen profiles and risk assessments.

Biosecurity measures for contagious mastitis control focus on preventing pathogen spread between animals. Milking order protocols milk uninfected cows before infected animals, reducing transmission through equipment. Separate milking units or thorough disinfection between infected and clean cows further limits spread. Single-use towels for udder preparation prevent pathogen transfer. Glove use and hand hygiene during milking reduce manual transmission. Culling of chronically infected cows removes reservoir animals from the herd. Purchased cattle should undergo mastitis screening during quarantine before herd integration.

Nutritional prevention strategies support immune function and tissue integrity. Selenium and vitamin E supplementation enhances neutrophil function and antimicrobial capacity. Copper and zinc adequacy maintains skin and teat integrity as physical barriers. Vitamin A supports epithelial tissue health throughout the mammary gland. Avoiding negative energy balance during transition reduces immunosuppression. Protein nutrition supports immunoglobulin production and cell-mediated immunity. Feed quality management prevents mycotoxin exposure that can impair immune function.

Management practices preventing mastitis address environmental pathogen exposure and teat condition. Proper milking procedures including adequate teat stimulation, correct attachment, and appropriate vacuum levels maintain teat tissue health. Post-milking teat disinfection reduces bacterial colonization of teat surfaces. Clean, dry bedding minimizes environmental pathogen contact with teats. Regular maintenance and testing of milking equipment ensures proper function. Prompt treatment of teat injuries prevents secondary infection. Appropriate drying off procedures reduce new infection risk during the dry period.

Quarantine and testing protocols enable early detection and control of mastitis pathogens. Bulk tank culture monitoring identifies new pathogen introduction. Individual cow culture programs detect infected animals for targeted management. Prepartum heifer screening identifies infections before first lactation. All purchased cattle should be tested before herd integration. Monitoring of fresh cow somatic cell counts reveals new infections requiring treatment. Regular program review with production medicine veterinarians optimizes screening efficiency.

Daily management and monitoring of dairy cows for mastitis integrates detection activities into routine milking procedures. Forestripping each quarter before unit attachment identifies abnormal milk before entering the bulk tank. Visual inspection of milk appearance during stripping detects flakes, clots, or discoloration. Udder observation before and after milking notes swelling, asymmetry, or lesions. Recording milk weights identifies quarters with declining production suggesting developing problems. Electronic cell count monitors at some parlors provide individual cow screening during milking. Communication between milking shifts ensures abnormalities receive appropriate follow-up.

Housing and environmental management significantly impacts mastitis incidence through pathogen exposure and cow comfort effects. Free-stall barns require appropriately sized stalls with clean, dry bedding surfaces to minimize udder contamination. Bedding material selection influences bacterial populations, with sand generally supporting lower counts than organic materials when properly maintained. Regular bedding addition and stall maintenance keeps contact surfaces clean. Alley scraping frequency affects manure accumulation and environmental pathogen loads. Ventilation and heat abatement reduce heat stress that compromises immune function. Adequate space allowance prevents overcrowding stress.

Herd health programs for mastitis control incorporate multiple components addressing detection, treatment, and prevention. Written protocols standardize approaches based on herd-specific pathogen patterns and treatment outcomes. Regular veterinary consultation evaluates program effectiveness and identifies improvement opportunities. Integration with reproductive, nutrition, and transition management programs addresses whole-cow health. Staff training ensures consistent implementation of mastitis control practices. Fresh cow monitoring programs provide intensive screening during the highest-risk period.

Record keeping and monitoring systems enable data-driven mastitis management. Individual cow somatic cell count records analyzed over time identify chronic infections and monitor herd trends. Clinical mastitis event recording by cow, quarter, severity, and pathogen reveals patterns guiding intervention. Treatment records document protocols used and outcomes achieved. Culling analysis quantifies mastitis-related removals and associated costs. Benchmarking against industry standards and peer operations identifies improvement opportunities. Regular review of key performance indicators maintains focus on udder health goals.

Economic considerations for mastitis management influence program design and resource allocation. Cost-benefit analysis of prevention investments including vaccination, bedding improvements, and equipment maintenance guides capital allocation. Treatment protocols balance efficacy against drug costs and withdrawal losses. Culling decisions weigh future production potential against chronic infection costs. Premium milk programs incentivize low somatic cell counts, rewarding investment in udder health. Labor allocation for monitoring, treatment, and prevention activities affects overall operation efficiency. Return on investment evaluation for various interventions supports evidence-based decision making.

High-risk breeds and species for mastitis include those with anatomical or functional characteristics increasing susceptibility. Holstein dairy cattle, representing the majority of commercial dairy cows, experience significant mastitis incidence related to high production levels and udder conformation characteristics in some lines. Jersey cattle generally demonstrate favorable udder health but may be susceptible to certain pathogen types. Brown Swiss and Guernsey breeds show intermediate characteristics. Dairy goats and sheep experience mastitis with different pathogen distributions than cattle. Within any breed, individual variation in mastitis susceptibility exists and responds to genetic selection.

Production type considerations significantly influence mastitis risk profiles across dairy operations. High-producing cows face elevated mastitis risk due to physiological stress, rapid milk accumulation, and frequent teat canal opening. Organic dairy operations cannot use antibiotics routinely, affecting treatment options and outcomes. Grazing-based systems face different pathogen exposures than confinement operations. Seasonal calving concentrates high-risk transition periods but may simplify management. Large commercial dairies implement systematized approaches while smaller operations may rely more on individual cow knowledge.

Genetic selection and testing strategies offer long-term opportunities for mastitis resistance improvement. Sire selection using predicted transmitting abilities for somatic cell score and clinical mastitis resistance improves daughter udder health. Genomic testing enables early identification of animals with favorable or unfavorable resistance profiles. Selection indices balancing production with health and fertility traits produce more robust animals. International genetic evaluation collaborations provide comprehensive data for selection decisions. Within-herd selection practices removing chronically infected animals improve future generation resistance while eliminating current reservoir animals.

Commonly co-occurring conditions with mastitis include metabolic disorders affecting periparturient cows. Subclinical hypocalcemia impairs immune function and increases mastitis susceptibility. Ketosis and fatty liver syndrome during negative energy balance compromise disease resistance. Retained placenta and metritis share immunosuppression risk factors with mastitis and may occur concurrently. Lameness and mastitis frequently occur together, with shared associations including stress, immune function, and management factors. Displaced abomasum and other digestive disorders may accompany severe mastitis, particularly following periparturient onset.

Conditions with similar symptoms requiring differentiation from mastitis include udder edema, which commonly occurs in fresh cows without infection. Udder trauma from mounting, kicks, or facility impacts produces painful swelling without bacterial involvement. Teat injuries including lacerations, cracks, and frostbite may or may not have secondary mastitis involvement. Milk leaking or dripping between milkings may indicate teat sphincter problems rather than infection. Systemic illness from other sources can cause fever, depression, and reduced appetite without udder involvement. Allergic reactions occasionally affect udder tissue.

Complications and sequelae of mastitis include chronic subclinical infection persisting despite treatment attempts. Permanent quarter damage reduces productive capacity for the remainder of the cow's life. Udder abscesses may develop from severe or inadequately treated infections. Fistulous tracts between quarters or to the skin surface occasionally develop. Systemic complications of severe mastitis include septicemia, endotoxemia, and multiple organ dysfunction. Gangrenous mastitis can result in udder tissue sloughing or necessitate amputation. Long-term consequences include elevated lifetime somatic cell counts, increased susceptibility to subsequent infections, and reduced productive longevity ultimately leading to premature culling.